世界の院内感染 (HAI) 診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4325 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、院内感染 (HAI) 診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子診断、血液検査、尿検査）、用途別市場規模（尿路感染症、肺炎、手術部位感染症、血流感染症、その他院内感染）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・院内感染 (HAI) 診断の市場動向 ・企業の競争状況、市場シェア ・院内感染 (HAI) 診断の種類別市場規模と予測2016-2027（分子診断、血液検査、尿検査） ・院内感染 (HAI) 診断の用途別市場規模と予測2016-2027（尿路感染症、肺炎、手術部位感染症、血流感染症、その他院内感染） ・院内感染 (HAI) 診断の北米市場規模2016-2027（アメリカ、カナダ） ・院内感染 (HAI) 診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・院内感染 (HAI) 診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・院内感染 (HAI) 診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・院内感染 (HAI) 診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（bioMérieux、Abbott Laboratories、Alere, Inc.、Roche、Siemens Healthcare、Becton Dickenson、Cepheid Inc.、Thermo Fisher Scientific、Seegene, Inc.、Qiagen） ・結論

A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI).

Market Analysis and Insights: Global Hospital-Acquired Infection (HAI) Diagnostic Market
The global Hospital-Acquired Infection (HAI) Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital-Acquired Infection (HAI) Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital-Acquired Infection (HAI) Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital-Acquired Infection (HAI) Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital-Acquired Infection (HAI) Diagnostic market.

Global Hospital-Acquired Infection (HAI) Diagnostic Scope and Market Size
Hospital-Acquired Infection (HAI) Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Infection (HAI) Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Diagnostics
Blood Tests
Urinalysis

Segment by Application
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
bioMérieux
Abbott Laboratories
Alere, Inc.
Roche
Siemens Healthcare
Becton Dickenson
Cepheid Inc.
Thermo Fisher Scientific
Seegene, Inc.
Qiagen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Diagnostics
1.2.3 Blood Tests
1.2.4 Urinalysis
1.3 Market by Application
1.3.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Urinary Tract Infections
1.3.3 Pneumonia
1.3.4 Surgical Site Infections
1.3.5 Bloodstream Infections
1.3.6 Other Hospital Infections
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Perspective (2016-2027)
2.2 Hospital-Acquired Infection (HAI) Diagnostic Growth Trends by Regions
2.2.1 Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital-Acquired Infection (HAI) Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Hospital-Acquired Infection (HAI) Diagnostic Industry Dynamic
2.3.1 Hospital-Acquired Infection (HAI) Diagnostic Market Trends
2.3.2 Hospital-Acquired Infection (HAI) Diagnostic Market Drivers
2.3.3 Hospital-Acquired Infection (HAI) Diagnostic Market Challenges
2.3.4 Hospital-Acquired Infection (HAI) Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Revenue
3.1.1 Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Infection (HAI) Diagnostic Revenue
3.4 Global Hospital-Acquired Infection (HAI) Diagnostic Market Concentration Ratio
3.4.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2020
3.5 Hospital-Acquired Infection (HAI) Diagnostic Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Infection (HAI) Diagnostic Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Infection (HAI) Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-Acquired Infection (HAI) Diagnostic Breakdown Data by Type
4.1 Global Hospital-Acquired Infection (HAI) Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Type (2022-2027)

5 Hospital-Acquired Infection (HAI) Diagnostic Breakdown Data by Application
5.1 Global Hospital-Acquired Infection (HAI) Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
6.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
6.2.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
6.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
6.3.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
6.4 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
6.4.1 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
7.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
7.2.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
7.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
7.3.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
7.4 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
7.4.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
8.2.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
8.3.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region
8.4.1 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
9.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
9.2.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
9.3.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
9.4.1 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type
10.2.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application
10.3.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country
10.4.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 bioMérieux
11.1.1 bioMérieux Company Details
11.1.2 bioMérieux Business Overview
11.1.3 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.1.4 bioMérieux Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.1.5 bioMérieux Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.2.4 Abbott Laboratories Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Alere, Inc.
11.3.1 Alere, Inc. Company Details
11.3.2 Alere, Inc. Business Overview
11.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.3.4 Alere, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.3.5 Alere, Inc. Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.4.4 Roche Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.5.4 Siemens Healthcare Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.5.5 Siemens Healthcare Recent Development
11.6 Becton Dickenson
11.6.1 Becton Dickenson Company Details
11.6.2 Becton Dickenson Business Overview
11.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.6.4 Becton Dickenson Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.6.5 Becton Dickenson Recent Development
11.7 Cepheid Inc.
11.7.1 Cepheid Inc. Company Details
11.7.2 Cepheid Inc. Business Overview
11.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.7.4 Cepheid Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.7.5 Cepheid Inc. Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.8.4 Thermo Fisher Scientific Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Seegene, Inc.
11.9.1 Seegene, Inc. Company Details
11.9.2 Seegene, Inc. Business Overview
11.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.9.4 Seegene, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.9.5 Seegene, Inc. Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Introduction
11.10.4 Qiagen Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
11.10.5 Qiagen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Molecular Diagnostics
Table 3. Key Players of Blood Tests
Table 4. Key Players of Urinalysis
Table 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Regions (2016-2021)
Table 9. Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Regions (2022-2027)
Table 11. Hospital-Acquired Infection (HAI) Diagnostic Market Trends
Table 12. Hospital-Acquired Infection (HAI) Diagnostic Market Drivers
Table 13. Hospital-Acquired Infection (HAI) Diagnostic Market Challenges
Table 14. Hospital-Acquired Infection (HAI) Diagnostic Market Restraints
Table 15. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Players (2016-2021)
Table 17. Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Infection (HAI) Diagnostic as of 2020)
Table 18. Ranking of Global Top Hospital-Acquired Infection (HAI) Diagnostic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hospital-Acquired Infection (HAI) Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital-Acquired Infection (HAI) Diagnostic Product Solution and Service
Table 22. Date of Enter into Hospital-Acquired Infection (HAI) Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Type (2016-2021)
Table 26. Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Application (2016-2021)
Table 30. Global Hospital-Acquired Infection (HAI) Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 62. bioMérieux Company Details
Table 63. bioMérieux Business Overview
Table 64. bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Product
Table 65. bioMérieux Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 66. bioMérieux Recent Development
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product
Table 70. Abbott Laboratories Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Alere, Inc. Company Details
Table 73. Alere, Inc. Business Overview
Table 74. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product
Table 75. Alere, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 76. Alere, Inc. Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Hospital-Acquired Infection (HAI) Diagnostic Product
Table 80. Roche Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. Siemens Healthcare Company Details
Table 83. Siemens Healthcare Business Overview
Table 84. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product
Table 85. Siemens Healthcare Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 86. Siemens Healthcare Recent Development
Table 87. Becton Dickenson Company Details
Table 88. Becton Dickenson Business Overview
Table 89. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product
Table 90. Becton Dickenson Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 91. Becton Dickenson Recent Development
Table 92. Cepheid Inc. Company Details
Table 93. Cepheid Inc. Business Overview
Table 94. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product
Table 95. Cepheid Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 96. Cepheid Inc. Recent Development
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 100. Thermo Fisher Scientific Recent Development
Table 101. Seegene, Inc. Company Details
Table 102. Seegene, Inc. Business Overview
Table 103. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product
Table 104. Seegene, Inc. Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 105. Seegene, Inc. Recent Development
Table 106. Qiagen Company Details
Table 107. Qiagen Business Overview
Table 108. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product
Table 109. Qiagen Revenue in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021) & (US$ Million)
Table 110. Qiagen Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Molecular Diagnostics Features
Figure 3. Blood Tests Features
Figure 4. Urinalysis Features
Figure 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application: 2020 VS 2027
Figure 6. Urinary Tract Infections Case Studies
Figure 7. Pneumonia Case Studies
Figure 8. Surgical Site Infections Case Studies
Figure 9. Bloodstream Infections Case Studies
Figure 10. Other Hospital Infections Case Studies
Figure 11. Hospital-Acquired Infection (HAI) Diagnostic Report Years Considered
Figure 12. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Regions: 2020 VS 2027
Figure 15. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Regions (2022-2027)
Figure 16. Global Hospital-Acquired Infection (HAI) Diagnostic Market Share by Players in 2020
Figure 17. Global Top Hospital-Acquired Infection (HAI) Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Infection (HAI) Diagnostic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2020
Figure 19. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Type (2016-2021)
Figure 20. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Type (2022-2027)
Figure 21. North America Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Hospital-Acquired Infection (HAI) Diagnostic Market Share by Type (2016-2027)
Figure 23. North America Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application (2016-2027)
Figure 24. North America Hospital-Acquired Infection (HAI) Diagnostic Market Share by Country (2016-2027)
Figure 25. United States Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Share by Type (2016-2027)
Figure 29. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application (2016-2027)
Figure 30. Europe Hospital-Acquired Infection (HAI) Diagnostic Market Share by Country (2016-2027)
Figure 31. Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Hospital-Acquired Infection (HAI) Diagnostic Market Share by Region (2016-2027)
Figure 41. China Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Share by Type (2016-2027)
Figure 49. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application (2016-2027)
Figure 50. Latin America Hospital-Acquired Infection (HAI) Diagnostic Market Share by Country (2016-2027)
Figure 51. Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Market Share by Country (2016-2027)
Figure 57. Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Hospital-Acquired Infection (HAI) Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. bioMérieux Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 61. Abbott Laboratories Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 62. Alere, Inc. Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 64. Siemens Healthcare Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 65. Becton Dickenson Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 66. Cepheid Inc. Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 68. Seegene, Inc. Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 69. Qiagen Revenue Growth Rate in Hospital-Acquired Infection (HAI) Diagnostic Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---